FR2480779B2
(fr)
*
|
1979-08-30 |
1986-07-18 |
Anvar |
Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
|
US6270955B1
(en)
|
1978-12-22 |
2001-08-07 |
Biogen, Inc. |
Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
|
IE52036B1
(en)
*
|
1979-05-24 |
1987-05-27 |
Univ California |
Non-passageable viruses
|
USRE34705E
(en)
*
|
1979-08-30 |
1994-08-23 |
Institut Pasteur |
Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby
|
FR2480780B1
(fr)
*
|
1980-04-22 |
1985-12-06 |
Pasteur Institut |
Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
|
DE3176404D1
(en)
*
|
1980-04-22 |
1987-10-08 |
Pasteur Institut |
Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
|
FR2495636B2
(fr)
*
|
1980-12-09 |
1989-10-06 |
Pasteur Institut |
Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
|
FI83662C
(fi)
*
|
1980-07-17 |
1991-08-12 |
Scripps Clinic Res |
Diagnostik antikropp och foerfarande foer dess framstaellning.
|
US5145782A
(en)
*
|
1980-12-08 |
1992-09-08 |
The Regents Of The University Of California |
DNA expression vector suitable for direct expression of a foreign gene
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
EP0062286A1
(en)
*
|
1981-03-31 |
1982-10-13 |
Albert Einstein College Of Medicine Of Yeshiva University |
Diagnostic test for hepatitis B virus
|
US5332664A
(en)
*
|
1981-07-15 |
1994-07-26 |
Celltech Limited |
Human calcitonin precursor polyprotein structural gene
|
GR76274B
(bg)
*
|
1981-08-04 |
1984-08-04 |
Univ California |
|
ATE53235T1
(de)
*
|
1981-08-04 |
1990-06-15 |
Univ California |
Synthese von menschlichen viralen antigenen mit hilfe von hefe.
|
US4769238A
(en)
|
1981-08-04 |
1988-09-06 |
The Regents Of The University Of California |
Synthesis of human virus antigens by yeast
|
NZ201705A
(en)
*
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
US4803164A
(en)
*
|
1981-08-31 |
1989-02-07 |
Genentech, Inc. |
Preparation of hepatitis b surface antigen in yeast
|
ZW18282A1
(en)
|
1981-08-31 |
1983-03-23 |
Genentech Inc |
Preparation of polypeptides in vertebrate cell culture
|
AU8746582A
(en)
*
|
1981-09-02 |
1983-03-10 |
Biogen N.V. |
Hepatitis b virus e type antigen
|
JPS5890517A
(ja)
*
|
1981-11-24 |
1983-05-30 |
Japan Found Cancer |
B型肝炎ウイルスの表面抗原を合成する新規な組換え体及びその製法
|
US4741901A
(en)
*
|
1981-12-03 |
1988-05-03 |
Genentech, Inc. |
Preparation of polypeptides in vertebrate cell culture
|
US7767449B1
(en)
*
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
US4603112A
(en)
*
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US4762708A
(en)
*
|
1982-02-18 |
1988-08-09 |
University Patents, Inc. |
Materials and methods for herpes simplex virus vaccination
|
AU1678783A
(en)
*
|
1982-07-20 |
1984-01-26 |
Molecular Genetics, Inc. |
Production of herpes simplex viral proteins
|
IL69202A
(en)
*
|
1982-09-08 |
1991-08-16 |
Smith Kline Rit |
Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
|
US4820642A
(en)
*
|
1983-04-04 |
1989-04-11 |
The Regents Of The University Of California |
Amplified expression vector
|
GB8321789D0
(en)
*
|
1983-08-12 |
1983-09-14 |
Biogen Nv |
Vaccines and compositions against hepatitis
|
FR2560890B1
(fr)
*
|
1984-03-07 |
1987-10-16 |
Grp Genie Genetique |
Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
|
AU579148B2
(en)
*
|
1984-03-09 |
1988-11-17 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
|
US5683688A
(en)
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
NZ212207A
(en)
*
|
1984-05-31 |
1991-07-26 |
Genentech Inc |
Recombinant lymphotoxin
|
EP0171908A3
(en)
*
|
1984-07-11 |
1987-07-15 |
Takeda Chemical Industries, Ltd. |
Hepatitis b virus surface antigen and production thereof
|
US4769239A
(en)
*
|
1984-08-21 |
1988-09-06 |
Merck & Co., Inc. |
Vaccine against varicella-zoster virus
|
US9328391B1
(en)
*
|
1984-08-22 |
2016-05-03 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Cloning and expression of HIV-1 DNA
|
US4722840A
(en)
*
|
1984-09-12 |
1988-02-02 |
Chiron Corporation |
Hybrid particle immunogens
|
JPS6170989A
(ja)
*
|
1984-09-13 |
1986-04-11 |
Takeda Chem Ind Ltd |
組み換えdnaおよびその用途
|
JPS6226300A
(ja)
*
|
1984-10-10 |
1987-02-04 |
セントコ−・インコ−ポレ−テツド |
Htlv−3dnaのクロ−ニングおよび発現
|
GB8431171D0
(en)
*
|
1984-12-11 |
1985-01-23 |
Technology Licence Co Ltd |
Monoclonal antibodies
|
US6534285B1
(en)
|
1984-12-24 |
2003-03-18 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
|
JPS61233700A
(ja)
*
|
1984-12-24 |
1986-10-17 |
ジエネンテク,インコ−ポレイテツド |
分子クロ−ンされたエイズ関連ポリペプチド
|
US5853978A
(en)
*
|
1985-12-04 |
1998-12-29 |
Genentech, Inc. |
Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use
|
FI861417A0
(fi)
*
|
1985-04-15 |
1986-04-01 |
Endotronics Inc |
Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
|
JPH084507B2
(ja)
*
|
1985-10-03 |
1996-01-24 |
武田薬品工業株式会社 |
新規dnaおよびポリペプチド
|
JPS62236496A
(ja)
*
|
1986-04-07 |
1987-10-16 |
Green Cross Corp:The |
HBsAgの製造方法
|
CA1310602C
(en)
*
|
1986-06-03 |
1992-11-24 |
Hajime Horii |
Yeast promoter and process for preparing heterologous protein
|
CA1338800C
(en)
*
|
1986-06-17 |
1996-12-17 |
Michael Houghton |
Hepatitis delta and diagnostics and vaccines
|
JPS63214181A
(ja)
*
|
1986-07-23 |
1988-09-06 |
ベ−リングベルケ、アクチエンゲゼルシャフト |
ヒト・パピロ−マ・ウイルス18型の発現生成物、これらのタンパク質に特異的な抗体およびこれらの抗体または対応するdnaを含む診断助剤
|
US4818688A
(en)
*
|
1986-11-21 |
1989-04-04 |
E. I. Du Pont De Nemours And Company |
Assays for antibody to hepatitis B core antigen
|
NZ219515A
(en)
*
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
CA1340173C
(en)
*
|
1987-03-10 |
1998-12-08 |
Chudi Guan |
Production and purification of a protein fused to a binding protein
|
CA1341074C
(en)
*
|
1987-06-22 |
2000-08-08 |
Hans A. Thoma |
Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
|
US4880750A
(en)
*
|
1987-07-09 |
1989-11-14 |
Miragen, Inc. |
Individual-specific antibody identification methods
|
JP3055687B2
(ja)
*
|
1987-08-10 |
2000-06-26 |
ザ ユニバーシティー オブ メルボルン |
Vp7をコードするヒトロタウイルス血清型4遺伝子9の分子クローニング、糖タンパク質特異的主要外部カプシド中和及びワクチンに使用するためのvp7及びそのフラグメントの発現
|
EP0311228A3
(en)
*
|
1987-10-09 |
1990-05-02 |
Repligen Corporation |
Recombinant polypeptides and their uses, including assay for aids virus
|
JP2791418B2
(ja)
|
1987-12-02 |
1998-08-27 |
株式会社ミドリ十字 |
異種蛋白質の製造方法、組換えdna、形質転換体
|
EP0491077A1
(en)
*
|
1990-12-19 |
1992-06-24 |
Medeva Holdings B.V. |
A composition used as a therapeutic agent against chronic viral hepatic diseases
|
DE4107612A1
(de)
|
1991-03-09 |
1992-09-10 |
Behringwerke Ag |
Rekombinante proteine mit der immunreaktivitaet des hepatitis b virus e antigens (hbeag), verfahren zu ihrer herstellung und ihre verwendung in immunoassays und impfstoffen
|
US5173427A
(en)
*
|
1991-08-01 |
1992-12-22 |
Becton Dickinson And Company |
Vectors and hosts with increased expression of HBCAG
|
US5175094A
(en)
*
|
1991-08-01 |
1992-12-29 |
Becton Dickinson And Company |
Increased expression of HBcAg
|
US5175272A
(en)
*
|
1991-08-01 |
1992-12-29 |
Becton Dickinson And Company |
DNA sequences with increased expression of HBcAg
|
US5780036A
(en)
*
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
US6607727B1
(en)
|
1991-08-26 |
2003-08-19 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
CA2110295A1
(en)
*
|
1992-03-30 |
1993-10-14 |
Tatsuya Kurihara |
Anti-hbs antibody genes and expression plasmids therefor
|
US6235288B1
(en)
|
1992-08-26 |
2001-05-22 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
|
FR2711670B1
(fr)
*
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
US5726011A
(en)
*
|
1994-03-31 |
1998-03-10 |
Virginia Commonwealth University |
Method for diagnosing chronic hepatitis B virus infection
|
DK0889120T3
(da)
*
|
1994-12-09 |
2002-07-22 |
Imp College Innovations Ltd |
Virulensgener i VGC2-regionen af Salmonella
|
US5993820A
(en)
*
|
1996-11-12 |
1999-11-30 |
Michigan State University |
Chimeric LTB vaccines
|
US20030100520A1
(en)
*
|
1997-01-21 |
2003-05-29 |
Philip Needleman |
Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
|
GB9712370D0
(en)
*
|
1997-06-14 |
1997-08-13 |
Aepact Ltd |
Therapeutic systems
|
TR200002338T2
(tr)
|
1998-02-12 |
2002-06-21 |
Immune Complex Corporation |
Stratejik olarak yenilenmiş hepatit B çekirdek proteinler.
|
JP2002511257A
(ja)
*
|
1998-04-14 |
2002-04-16 |
カイロン コーポレイション |
目的の遺伝子を発現するための非クローニング技術
|
ES2356863T3
(es)
*
|
1998-09-04 |
2011-04-13 |
Emergent Product Development Uk Limited |
Mutantes de spi2 de salmonella atenuada como portadores de antígenos.
|
PL348766A1
(en)
|
1998-12-04 |
2002-06-03 |
Biogen |
Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
|
US6551820B1
(en)
|
1998-12-23 |
2003-04-22 |
Boyce Thompson Institute For Plant Research |
Expression of immunogenic hepatitis B surface antigens in transgenic plants
|
GB9910812D0
(en)
*
|
1999-05-10 |
1999-07-07 |
Microscience Ltd |
Vaccine composition
|
US6268178B1
(en)
|
1999-05-25 |
2001-07-31 |
Phage Biotechnology Corp. |
Phage-dependent super-production of biologically active protein and peptides
|
GB0008419D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Bioinvent Int Ab |
A method for invitro molecular evolution of antibody function
|
GB0008966D0
(en)
|
2000-04-13 |
2000-05-31 |
Imp College Innovations Ltd |
Vectors for gene therapy
|
US7001760B2
(en)
*
|
2000-04-20 |
2006-02-21 |
Wang-Schick Ryu |
Hepatitis B virus vectors for gene therapy
|
US6583279B1
(en)
|
2001-01-26 |
2003-06-24 |
Becton, Dickinson And Company |
Sequences and methods for detection of hepatitis B virus
|
US7202354B2
(en)
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
US8876532B2
(en)
|
2002-07-31 |
2014-11-04 |
Dentsply International Inc. |
Bone repair putty
|
GB0226105D0
(en)
*
|
2002-11-08 |
2002-12-18 |
St Georges S Entpr Ltd |
Pain relief agents
|
GB0304993D0
(en)
*
|
2003-03-05 |
2003-04-09 |
Univ Nottingham Trent |
Novel screening method
|
PL1605971T3
(pl)
*
|
2003-03-26 |
2010-10-29 |
Wyeth Llc |
Kompozycja immunogenna i sposoby
|
CA2552590A1
(en)
*
|
2004-01-05 |
2005-07-21 |
Emd Lexigen Research Center Corp. |
Interleukin-12 targeted to oncofoetal fibronectin
|
GB0420091D0
(en)
*
|
2004-09-10 |
2004-10-13 |
Univ Nottingham Trent |
Medical implant materials
|
US20060193849A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Antisoma Plc |
Biological materials and uses thereof
|
GB0514661D0
(en)
*
|
2005-07-16 |
2005-08-24 |
Medical Res Council |
Methods
|
JP4352032B2
(ja)
|
2005-08-23 |
2009-10-28 |
シャープ株式会社 |
携帯通信機器
|
DE602005016112D1
(de)
|
2005-09-05 |
2009-10-01 |
Immatics Biotechnologies Gmbh |
Tumorassoziierte Peptide, die HLA Klasse I oder II-Moleküle binden, und anti-Tumor Impfstoffe
|
ATE461214T1
(de)
|
2005-09-05 |
2010-04-15 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
|
GB0519398D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Antisoma Plc |
Biological materials and uses thereof
|
GB0607354D0
(en)
|
2006-04-12 |
2006-05-24 |
Bioinvent Int Ab |
Agent, Composition And Method
|
GB0607798D0
(en)
*
|
2006-04-20 |
2006-05-31 |
Alligator Bioscience Ab |
Novel polypeptides and use thereof
|
US20090181115A1
(en)
*
|
2006-05-31 |
2009-07-16 |
Wendy Filsell |
Method of Screening for Compounds That Alter Skin and/or Hair Pigmentation
|
KR100836745B1
(ko)
*
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Hbv 백신 및 그의 제조 방법
|
MX2010001086A
(es)
|
2007-07-27 |
2010-04-09 |
Immatics Biotechnologies Gmbh |
Nueva inmunoterapia contra tumores neuronales y cerebrales.
|
HUE026142T2
(en)
|
2007-07-27 |
2016-05-30 |
Immatics Biotechnologies Gmbh |
New immunogenic epitope for immunotherapy
|
WO2009058564A2
(en)
|
2007-11-01 |
2009-05-07 |
Maxygen, Inc. |
Immunosuppressive polypeptides and nucleic acids
|
US20100249373A1
(en)
*
|
2007-11-27 |
2010-09-30 |
Richard Martin Ogborne |
Screening methods
|
CN102851313B
(zh)
*
|
2008-01-28 |
2015-01-28 |
多贝尔有限公司 |
一种乙型肝炎疫苗及其制备工艺
|
ES2554981T3
(es)
|
2008-03-27 |
2015-12-28 |
Immatics Biotechnologies Gmbh |
Nueva inmunoterapia contra tumores neuronales y cerebrales
|
PL2119726T5
(pl)
|
2008-05-14 |
2018-04-30 |
Immatics Biotechnologies Gmbh |
Nowe i silne peptydy MHC klasy II pochodzące z surwiwiny i neurokanu
|
EP2326344A4
(en)
|
2008-06-16 |
2013-08-07 |
Prokarium Ltd |
VACCINES WITH SALMONELLA VECTOR AGAINST CHLAMYDIA AND METHOD OF ADMINISTRATION
|
ES2536465T3
(es)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
GB0905790D0
(en)
|
2009-04-03 |
2009-05-20 |
Alligator Bioscience Ab |
Novel polypeptides and use thereof
|
CN102712695B
(zh)
|
2009-12-18 |
2015-01-21 |
堪瑟拉公司 |
能够诱导细胞死亡的ror1生物抑制剂
|
GB201019331D0
(en)
|
2010-03-19 |
2010-12-29 |
Immatics Biotechnologies Gmbh |
Methods for the diagnosis and treatment of cancer based on AVL9
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
GB201020995D0
(en)
|
2010-12-10 |
2011-01-26 |
Bioinvent Int Ab |
Biological materials and uses thereof
|
US9452212B2
(en)
|
2011-04-14 |
2016-09-27 |
Dynavax Technologies Corporation |
Methods and compositions for eliciting an immune response against hepatitis B virus
|
GB2490655A
(en)
|
2011-04-28 |
2012-11-14 |
Univ Aston |
Modulators of tissue transglutaminase
|
GB201115280D0
(en)
|
2011-09-05 |
2011-10-19 |
Alligator Bioscience Ab |
Antibodies, uses and methods
|
GB201219678D0
(en)
|
2012-11-01 |
2012-12-12 |
Benf Ab |
Ketone body inhibitors and uses thereof
|
ES2734374T3
(es)
|
2013-03-01 |
2019-12-05 |
Boehringer Ingelheim Animal Health Usa Inc |
Cuantificación de composiciones de vacuna
|
TWI777197B
(zh)
|
2013-08-05 |
2022-09-11 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類,細胞及其用於治療多種腫瘤的用途,其製造方法及包含其等之醫藥組成物(六)
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
MD3388075T2
(ro)
|
2015-03-27 |
2023-10-31 |
Immatics Biotechnologies Gmbh |
Noi peptide și combinații de peptide pentru utilizare în imunoterapia împotriva unor diverse tumori (SEQ ID 25 - MXRA5-003)
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
MA42294B1
(fr)
|
2015-07-01 |
2020-11-30 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
MA51531A
(fr)
|
2015-07-06 |
2020-11-11 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et nouvelle combinaison de peptides à utiliser dans l'immunothérapie du cancer de l' oesophage et d'autres cancers
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
GB201602918D0
(en)
|
2016-02-19 |
2016-04-06 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
|
CN116375797A
(zh)
|
2016-03-01 |
2023-07-04 |
伊玛提克斯生物技术有限公司 |
用于膀胱癌和其他癌症免疫治疗的肽、肽组合物和细胞类药物
|
IL261787B2
(en)
|
2016-03-16 |
2023-03-01 |
Immatics Biotechnologies Gmbh |
Nucleic acid-treated t-cells and receptor t-cells for use in immunotherapy against types of cancer
|
TWI826891B
(zh)
|
2016-03-16 |
2023-12-21 |
德商英麥提克生物技術股份有限公司 |
轉染 t 細胞和 t 細胞受體用於癌症免疫治療
|
EP4219524A3
(en)
|
2016-04-06 |
2023-10-18 |
immatics biotechnologies GmbH |
Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
|
TWI796299B
(zh)
|
2016-08-26 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
MA47367B1
(fr)
|
2017-01-27 |
2023-06-28 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides à utiliser en immunothérapie contre le cancer de l'ovaire et d'autres cancers
|
WO2018189148A1
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
CR20210159A
(es)
|
2017-04-10 |
2021-05-21 |
Immatics Biotechnologies Gmbh |
Péptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cáncer (divisional de solicitud 2019-0508)
|
WO2018189152A2
(en)
|
2017-04-10 |
2018-10-18 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers
|
WO2019007974A1
(en)
|
2017-07-07 |
2019-01-10 |
Immatics Biotechnologies Gmbh |
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NSCLC, CPPC AND OTHER CANCERS
|
SG11201913302SA
(en)
|
2017-07-07 |
2020-01-30 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers
|
DE102018107224A1
(de)
|
2018-02-21 |
2019-08-22 |
Immatics Biotechnologies Gmbh |
Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
TW202016131A
(zh)
|
2018-05-16 |
2020-05-01 |
德商英麥提克生物技術股份有限公司 |
用於抗癌免疫治療的肽
|
US10925947B2
(en)
|
2018-06-29 |
2021-02-23 |
Immatics Biotechnologies Gmbh |
A*03 restricted peptides for use in immunotherapy against cancers and related methods
|
TW202019955A
(zh)
|
2018-07-31 |
2020-06-01 |
德商英麥提克生物技術股份有限公司 |
B*07 限制肽和肽組合的抗癌免疫治療和相關方法
|
US11945850B2
(en)
|
2018-09-17 |
2024-04-02 |
Immatics Biotechnologies Gmbh |
B*44 restricted peptides for use in immunotherapy against cancers and related methods
|
TW202024121A
(zh)
|
2018-09-18 |
2020-07-01 |
德商英麥提克生物技術股份有限公司 |
A*01 限制肽和肽組合物在抗癌免疫治療中的用途和相關方法
|
TW202039535A
(zh)
|
2018-12-18 |
2020-11-01 |
德商英麥提克生物技術股份有限公司 |
B*08限制肽和肽組合物抗癌免疫治療和相關方法
|
DE102020125457A1
(de)
|
2020-09-29 |
2022-03-31 |
Immatics Biotechnologies Gmbh |
Amidierte Peptide und ihre deamidierten Gegenstücke, die durch HLA-A*02-Moleküle präsentiert werden, zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten
|
TW202229312A
(zh)
|
2020-09-29 |
2022-08-01 |
德商英麥提克生物技術股份有限公司 |
由非hla-a*02顯露以用於不同類型癌症之免疫治療的醯胺化肽及其脫醯胺化對應物
|
TW202241925A
(zh)
|
2021-01-15 |
2022-11-01 |
德商英麥提克生物技術股份有限公司 |
用於不同類型癌症免疫治療的hla展示肽
|